Cite
HARVARD Citation
Marshall, A. et al. (2020). Treatment of cancer‐associated venous thromboembolism: 12‐month outcomes of the placebo versus rivaroxaban randomization of the SELECT‐D Trial (SELECT‐D: 12m). Journal of thrombosis and haemostasis. pp. 905-915. [Online].